Section Editors

Stefan Evers - Professor of Neurology and Clinical Neurophysiology, Department of Neurology, University of Münster

Stefan Evers

Professor of Neurology and Clinical Neurophysiology, Department of Neurology, University of Münster

Stefan Evers is Head of the Department of Neurology at the Lindenbrunn Hospital in Coppenbrügge, Germany, and Professor of Neurology and Clinical Neurophysiology at the University of Münster, Germany. Professor Evers also holds a PhD in Musicology. He is Honorary Secretary of the International Headache Society and Chair of the Headache Panel of the European Academy of Neurology. His main research interests are headache, pain, epilepsy, stroke and the link between music and medicine. He has authored 320 original publications, undertakes peer reviews and is Editor or Co-Author of eight books.

Latest Articles

Latest Videos

Video List based on Category on Node Page

Latest Videos

Prof. Matthias Koepp and Dr Anna Barnes discuss Project 34, whereby they are using PET/MRI to investigate epilepsy.
A single seizure clinic model implemented in Canada reduced wait times for first assessment 50% to 90% among patients with a single unprovoked first seizure. Syed Rizvi, MD, a senior neurology resident at the University of Saskatchewan and study researcher, explains the benefits of the model for patients with epilepsy.
Patients who suffer their first seizure are expected to have several questions. In some instances, one question may be why their doctor is waiting until a second seizure to begin treatment. A new guideline from the American Academy of Neurology looked to answer that question for doctors and patients alike.

Epilepsy INSIGHTS

The touchNEUROLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of neurology:

Press Briefing
Eslicarbazepine acetate appears to have no significant detrimental effect on neurocognitive function in children with epilepsy

22 June 2017, Lyon Convention Centre, Lyon, France
Catherine Amey, Senior Medical Writer, Touch Medical Media, UK
Jon Shepheard, Neurology Account Director, Touch Medical Media, UK

Insight
New data shows that eslicarbazepine acetate is effective and well-tolerated in epilepsy: the ESLADOBA study

Katrina Mountfort, Freelance Medical Writer for Touch Medical Media, UK